BMEA vs DXCM · $94.7M cap vs P/E 63, rev $4.03B
Biomea Fusion Inc (BMEA) versus DexCom Inc (DXCM) — a side-by-side from cached financials, not a winner call.
Biomea Fusion Inc (BMEA) is a biotechnology company listed on US.
DexCom Inc (DXCM) is a medical devices company listed on US.
BMEA does not have a complete income-statement cache yet.
Latest reported DXCM revenue for 2024-12-31 was $4.03B. Net income was $576.2M. Revenue was up 11.3% from 2023-12-31 to 2024-12-31. DXCM currently screens at market cap $32.84B and trailing P/E 62.5.
BMEA currently screens at market cap $94.7M. DXCM currently screens at market cap $32.84B and trailing P/E 62.5.
Not investment advice. Open the BMEA and DXCM stock pages for the full models.
Not investment advice.